Gandeeva Therapeutics

Vancouver, Canada

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Jan 2022

Series A

Artificial Intelligence (AI)Biotechnology Health Care Life Science

Top Investors

Air Street CapitalObvious VenturesLux CapitalAmplitude Venture CapitalLeaps by Bayer

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gandeeva Therapeutics

Who are Gandeeva Therapeutics's investors?

Gandeeva Therapeutics's investors include Air Street Capital, Obvious Ventures, Lux Capital, Amplitude Venture Capital, Leaps by Bayer.

Where is Gandeeva Therapeutics headquartered?

Gandeeva Therapeutics is headquartered in Vancouver, Canada.

What does Gandeeva Therapeutics do?

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

What stage is Gandeeva Therapeutics at?

Gandeeva Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 31, 2022.

MLA

"Gandeeva Therapeutics — Funding & Investors." VCBacked, January 31, 2022, https://www.vcbacked.co/company/gandeeva-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Gandeeva Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gandeeva-therapeutics

Wikipedia (cite web)

{{cite web |title=Gandeeva Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gandeeva-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 31, 2022.